La cadena de opciones muestra datos clave de las opciones de acciones de Organon a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Organon..

Organon (NYSE:OGN) Bolsa, Cadena de Opciones

Organon

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Organon & Co

Origin Protocol - United States Dollar

OROGEN ROYALTIES INC by Orogen Royalties Inc.

Orogen Royalties Inc

ORGANA TECHS GRP INC by Organa Technologies Group, Inc.

Earnings

News

Rafael Holdings Q2 EPS $(0.19) Down From $0.25 YoY, Sales $77K Up From $68K YoY

Earnings Beats

Earnings Misses

AFYA

Afya Q4 2024 Adj EPS R$2.10 Beats R$1.69 Estimate, Sales R$849.01M Miss R$849.90M Estimate

Editor&#8217;s Note: The headline has been updated for clarity.
Goldman Sachs forecasts a surge in U.S. copper imports soon, driven by expectations of tariffs from President Donald Trump's <a href="https://www.benzinga.com/topic/donald-trump" target="_blank" rel="noreferrer noopener">administration</a>.
Per Reuters' <a target="_blank" href="https://www.reuters.com/markets/commodities/goldman-sachs-anticipates-surge-us-copper-net-imports-2025-03-11/" rel="noreferrer noopener">report</a>, the investment bank expects a 25% duty on copper imports by year's end, incentivizing stockpiling to frontrun the legislative. As a result, U.S. net copper imports could surge by 50-100%, adding between 200,000 to 300,000 metric tons to domestic inventories by Q3.
If this projection materializes, U.S. copper stockpiles could swell from 95,000 tons to as much as 400,000 tons or around half of global reported inventories – leaving the international market at historically low inventory levels.
For 2025, Goldman sees a 180,000-ton global copper deficit as growing demand for electrification, economic stimulus measures in China, and slow mine growth materialize. The bank sees the supply imbalance more pronounced in the second half of the year as a catalyst for higher prices.
"We maintain our forecast that the LME three-month price will average $10,200 per ton in Q3 2024 and see the impact of inventory dislocation predominantly in timespreads," the bank noted. Current three-month copper contracts on the London Metal Exchange were trading at $9,528.50 per ton as of Wednesday morning.
The largest U.S. copper producer, Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), could benefit from this scenario, particularly if copper is classified as a critical mineral.
In a recent <a target="_blank" href="https://www.reuters.com/markets/commodities/ceraweek-freeport-sees-500-million-annual-boost-if-trump-declares-copper-2025-03-10/" rel="noreferrer noopener">interview</a>, CEO Kathleen Quirk expressed optimism that the Trump administration could make this move soon, unlocking the federal tax incentives to support domestic production.
"Having the incentives and clarity around those would be a big plus for the domestic copper industry," Quirk said. Such a designation would enable Freeport to claim more than $500 million annually in tax credits tied to the Inflation Reduction Act.
Freeport-McMoRan operates seven copper mines across the U.S. and one of two domestic copper smelters. The firm doesn't export any domestically produced copper, making it a key supplier in any scenario restricting imports.
However, production costs in the U.S. are higher than in Freeport's international operations due to lower ore grades, making policy support a crucial factor.
Per the <a target="_blank" href="https://mms.businesswire.com/media/20250122679192/en/2360933/1/FCX_250123_4Q_2024_Earnings_Release.pdf" rel="noreferrer noopener">latest guidance</a>, the company expects its U.S. copper production to increase by 8% in 2025, with further growth in subsequent years. Opportunities include doubling the concentrator capacity at its Bagdad operation in Arizona, which could add 200-250 million pounds of copper annually.
Quirk also hinted at a possible <a target="_blank" href="https://www.benzinga.com/25/03/44216408/dr-congo-explores-a-minerals-for-security-deal-with-the-us" rel="noreferrer noopener">return to the Democratic Republic of Congo</a>, where Freeport previously owned the Kisanfu copper-cobalt project before selling it to China Molybdenum in 2020. "We would be interested in going back for the right opportunity," she said, adding that Freeport would seek to be the operator of any project if it re-enters the DRC.
Price Watch: Freeport-McMoRan has declined 5.28% year-to-date. The stock is up 1.56% to $36.44 premarket at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44243837/iron-ore-production-to-accelerate-until-2030-study-says" target="_blank" rel="noreferrer noopener">Iron Ore Production To Accelerate Until 2030, Study Says</a></li>
</ul>
Photo via Shutterstock

Government

Large Cap

Guidance

Commodities

Politics

Legal

Markets

Trading Ideas

COPX

CPER

FQVLF

JJCTF

LUNMF

MTAL

SCCO

Goldman Sachs Sees Copper Imports Increasing Ahead Of Tariffs As FCX Positions To Benefit (UPDATED)

Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) has outperformed the market over the past 15 years by 4.37% on an annualized basis producing an average annual return of 15.32%. Currently, Autodesk has a market capitalization of $52.60 billion. 
Buying $100 In ADSK: If an investor had bought $100 of ADSK stock 15 years ago, it would be worth $839.33 today based on a price of $246.93 for ADSK at the time of writing.
<h3>Autodesk's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741902309_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADSK

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

LEGT

Legato Merger Corp. III Reveals Receipt Of Audit Opinion With Going Concern Explanation

The previously disclosed amount for Q4 2024 and FY 2024 was reduced by $2.81 million, reflecting updated valuation inputs. The 2024 10-K reflects the revised results.

Tucows Reports Amendment To Q4 Earnings, Reduces Previously Disclosed Non-cash Impairment Charge For Property And Equipment

Atlanticus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATLC#NASDAQ">ATLC</a>) reported quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.26 by 12.7 percent. This is a 29.09 percent increase over earnings of $1.10 per share from the same period last year. The company reported quarterly sales of $353.49 million which missed the analyst consensus estimate of $355.02 million by 0.43 percent. This is a 14.37 percent increase over sales of $309.09 million the same period last year.

ATLC

Atlanticus Holdings Q4 2024 GAAP EPS $1.42 Beats $1.26 Estimate, Sales $353.49M Miss $355.02M Estimate

Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) has outperformed the market over the past 5 years by 32.81% on an annualized basis producing an average annual return of 49.69%. Currently, Royal Caribbean Gr has a market capitalization of $55.39 billion. 
Buying $1000 In RCL: If an investor had bought $1000 of RCL stock 5 years ago, it would be worth $6,943.89 today based on a price of $205.81 for RCL at the time of writing.
<h3>Royal Caribbean Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741901421_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Royal Caribbean Gr 5 Years Ago Would Be Worth Today

Wheaton Precious Metals Provides 2025 Production Guidance Of 600,000 - 670,000 GEOs; Expects Production To Increase By 40% Over Next Five Years

Wheaton Precious Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPM#NYSE">WPM</a>) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.43 by 2.09 percent. This is a 20.94 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $380.52 million which missed the analyst consensus estimate of $394.50 million by 3.54 percent. This is a 21.39 percent increase over sales of $313.47 million the same period last year.

Wheaton Precious Metals Q4 2024 Adj EPS $0.44 Beats $0.43 Estimate, Sales $380.52M Miss $394.50M Estimate

Blink Charging Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) released its fourth-quarter results after Thursday's closing bell. Here's a look at the key figures<a href="https://www.benzinga.com/pressreleases/25/03/g44317190/blink-charging-announces-fourth-quarter-and-full-year-2024-results"> from the report.&nbsp;&nbsp;</a>
The Details:&nbsp;Blink Charging reported quarterly losses of&nbsp;15 cents&nbsp;per share, which beat the analyst consensus estimate for losses of 17 cents. Quarterly revenue came in at $30.18 million, which missed the analyst consensus estimate of&nbsp;$30.52 million&nbsp;and is down from revenue of&nbsp;$42.71 million&nbsp;from the same period last year.
Read Next: <a href="https://www.benzinga.com/government/regulations/25/03/44310724/doge-cuts-to-ftc-sow-confusion-in-case-against-amazon">DOGE Cuts To FTC Sow Confusion In Case Against Amazon</a>&nbsp;
For the fourth quarter, Blink reported: 
<ul>
<li>Product Revenues of $17.2 million in the fourth quarter of 2024, compared to $33.4 million in the fourth quarter of 2023. </li>
<li>Service Revenues, which consist of charging service revenues, network fees and car-sharing service revenues, increased 24% to $9.8 million in the fourth quarter of 2024, primarily driven by greater utilization of chargers, an increased number of chargers on the Blink networks and revenues associated with car-sharing programs.</li>
<li>Other Revenues, which are comprised of warranty fees, grants and rebates and additional sources, were $3.2 million in the fourth quarter of 2024. The increase was primarily driven by higher warranty revenue.</li>
</ul>
&#8220;During 2024, we achieved&nbsp;record charging revenue and significantly grew the total number of Blink-owned chargers. That said, as we expected, product revenues declined in the fourth quarter and for the full year in comparison to exceptionally strong equipment sales&nbsp;in 2023. In addition, we reduced operating expenses and cash burn across the company,&#8221; said Mike&nbsp;Battaglia, CEO of Blink Charging.
&#8220;We are focused on achieving profitability and expanding our charging network globally. Our flexible business models, advanced software and network, and portfolio of diverse charging solutions position us as a charging infrastructure leader,&#8221; Battaglia added. 
BLNK Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Blink Charging shares are up 2.18% after-hours Thursday at 92 cents.  
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/econ-s/25/03/44307019/latest-inflation-data-excludes-tariffs-trump-policy-changes-2025-will-be-much-more-volatile-year-economist-says">Latest Inflation Data Excludes Tariffs, Trump Policy Changes: 2025 Will Be &#8216;Much More Volatile Year,&#8217; Economist Says</a></li>
</ul>
Image: Shutterstock

After-Hours Center

Movers

Tech

BLNK

Blink Charging Shares Up Slightly After Q4 Results: Here's Why

RDUS

Trading Halt: Halt status updated at 5:25:00 PM ET: Quotation Resumption: News and Resumption Times

Blink Charging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 46.43 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $30.18 million which missed the analyst consensus estimate of $30.52 million by 1.12 percent. This is a 29.34 percent decrease over sales of $42.71 million the same period last year.

CORRECTION: Blink Charging Q4 2024 Adj EPS $(0.15) Beats $(0.17) Estimate, Sales $30.18M Miss $30.52M Estimate

Chad Holmes, CRA's Chief Corporate Development Officer and former CFO, will serve as interim CFO while the Company conducts a search for a permanent replacement, which is being supported by a leading executive search firm.

Management

CRAI

Charles River Associates Says Daniel Mahoney, CRA's CFO, Will Transition Out Of His Role, Effective April 11, 2025

Buybacks

OTEX

OpenText Increases Previously Announced Fiscal 2025 Normal Course Issuer Bid By $150M

<h3>Gainers</h3>
<ul>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) shares increased by 79.8% to $1.1 during Thursday's after-market session. The company's market cap stands at $8.6 million. </li>
<li>Purple Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) shares moved upwards by 30.36% to $0.86. The company's market cap stands at $93.0 million. The company's, Q4 earnings came out today. </li>
<li>Cheetah Net Supply Chain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNT#NASDAQ">CTNT</a>) shares rose 6.46% to $1.74. The market value of their outstanding shares is at $5.5 million. </li>
<li>Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) shares moved upwards by 6.05% to $333.5. The market value of their outstanding shares is at $15.4 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Afya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFYA#NASDAQ">AFYA</a>) stock rose 5.98% to $17.19. The market value of their outstanding shares is at $1.5 billion. </li>
<li>Motorcar Parts of America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPAA#NASDAQ">MPAA</a>) stock rose 5.81% to $10.74. The market value of their outstanding shares is at $210.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Xponential Fitness (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) shares fell 21.6% to $9.5 during Thursday's after-market session. The company's market cap stands at $306.7 million. As per the news, the Q4 earnings report came out today. </li>
<li>MKDWell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) stock decreased by 18.54% to $0.32. The market value of their outstanding shares is at $5.9 million. </li>
<li>Linkage Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCB#NASDAQ">LGCB</a>) shares decreased by 16.49% to $0.19. The market value of their outstanding shares is at $5.9 million. </li>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) shares decreased by 9.48% to $0.15. The company's market cap stands at $3.2 million. </li>
<li>Jeffs Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) stock fell 7.3% to $1.27. The company's market cap stands at $2.2 million. </li>
<li>Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) shares decreased by 6.11% to $12.0. The company's market cap stands at $230.0 million. As per the news, the Q4 earnings report came out today. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTNT

JFBR

LGCB

MKDW

MPAA

PRPL

ULTA

XPOF

ZUMZ

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>TNF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNFA#NASDAQ">TNFA</a>) shares moved upwards by 19.6% to $0.41 during Thursday's after-market session. The market value of their outstanding shares is at $1.1 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock rose 14.83% to $0.69. The company's market cap stands at $16.3 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares moved upwards by 14.28% to $0.8. The market value of their outstanding shares is at $3.3 million. </li>
<li>Passage Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) shares rose 9.69% to $0.43. The company's market cap stands at $26.5 million. </li>
<li>OSR Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSRH#NASDAQ">OSRH</a>) stock moved upwards by 9.54% to $1.6. The market value of their outstanding shares is at $30.8 million. </li>
<li>Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) shares increased by 8.0% to $0.54. The company's market cap stands at $31.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NAYA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAYA#NASDAQ">NAYA</a>) stock decreased by 17.5% to $0.27 during Thursday's after-market session. The company's market cap stands at $1.3 million. </li>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) shares fell 11.76% to $0.23. The market value of their outstanding shares is at $6.8 million. </li>
<li>IMAC Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BACK#NASDAQ">BACK</a>) shares fell 8.53% to $0.55. The market value of their outstanding shares is at $1.8 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock decreased by 7.67% to $13.01. The company's market cap stands at $169.2 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares decreased by 7.44% to $3.61. The company's market cap stands at $5.0 million. As per the news, the Q4 earnings report came out 3 days ago. </li>
<li>Aspira Womens Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWH#NASDAQ">AWH</a>) stock decreased by 7.17% to $0.14. The market value of their outstanding shares is at $2.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BACK

BSGM

ELEV

ENSC

NAYA

OSRH

PASG

PLRZ

TNFA

Longevity Health Holdings, Inc. - Common Stock

XAGE

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) stock increased by 12.2% to $0.24 during Thursday's after-market session. </li>
<li>Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) stock moved upwards by 11.86% to $0.48. The market value of their outstanding shares is at $8.6 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) shares moved upwards by 9.47% to $1.27. The market value of their outstanding shares is at $13.9 million. </li>
<li>Pangaea Logistics Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANL#NASDAQ">PANL</a>) stock increased by 6.4% to $5.15. The company's market cap stands at $334.5 million. The company's, Q4 earnings came out today. </li>
<li>Blade Air Mobility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>) shares rose 5.61% to $3.2. The market value of their outstanding shares is at $250.6 million. As per the news, the Q4 earnings report came out today. </li>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) shares rose 5.61% to $0.22. The company's market cap stands at $12.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares declined by 8.1% to $1.35 during Thursday's after-market session. The company's market cap stands at $69.2 million. As per the press release, Q4 earnings came out today. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) stock decreased by 7.11% to $0.14. The company's market cap stands at $18.5 million. </li>
<li>Icon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) stock decreased by 6.55% to $0.13. The market value of their outstanding shares is at $3.6 million. </li>
<li>PS International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) stock decreased by 6.13% to $0.46. The company's market cap stands at $11.1 million. </li>
<li>Linkers Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNKS#NASDAQ">LNKS</a>) stock fell 5.75% to $0.53. The company's market cap stands at $7.1 million. </li>
<li>SUNation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNE#NASDAQ">SUNE</a>) stock fell 5.16% to $0.3. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AREB

BLDE

HKPD

ICON

ILAG

LNKS

Nuveen Insured California Premium Fund Ii

PANL

PSIG

SUNE

12 Industrials Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) shares increased by 78.4% to $28.31 during Thursday's after-market session. The market value of their outstanding shares is at $1.4 billion. </li>
<li>A10 Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATEN#NYSE">ATEN</a>) stock rose 19.35% to $19.55. The market value of their outstanding shares is at $1.4 billion. </li>
<li>Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) shares rose 15.05% to $63.6. The market value of their outstanding shares is at $11.7 billion. The company's, Q4 earnings came out today. </li>
<li>Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) stock moved upwards by 11.55% to $36.49. The market value of their outstanding shares is at $3.1 billion. As per the press release, Q4 earnings came out today. </li>
<li>Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) shares moved upwards by 11.08% to $0.65. The company's market cap stands at $18.2 million. </li>
<li>Frequency Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEIM#NASDAQ">FEIM</a>) shares rose 10.04% to $15.47. The market value of their outstanding shares is at $148.7 million. The company's, Q3 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Turtle Beach (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBCH#NASDAQ">TBCH</a>) stock declined by 16.0% to $12.0 during Thursday's after-market session. The market value of their outstanding shares is at $240.9 million. As per the news, the Q4 earnings report came out today. </li>
<li>Lightwave Logic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWLG#NASDAQ">LWLG</a>) shares declined by 13.63% to $1.14. The company's market cap stands at $139.5 million. </li>
<li>AuthID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>) stock decreased by 11.77% to $4.2. The company's market cap stands at $45.8 million. The company's, Q4 earnings came out today. </li>
<li>Mawson Infra Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) shares declined by 10.79% to $0.44. The company's market cap stands at $8.1 million. </li>
<li>SemiLEDs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) shares decreased by 7.48% to $1.61. The market value of their outstanding shares is at $11.6 million. </li>
<li>EverCommerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVCM#NASDAQ">EVCM</a>) stock declined by 6.15% to $8.4. The company's market cap stands at $1.5 billion. The company's, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAOI

ATEN

AUID

CMBM

EVCM

FEIM

LEDS

LWLG

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

RBRK

SMTC

TBCH

12 Information Technology Stocks Moving In Thursday's After-Market Session

Radius Recycling Agrees To Be Acquired By US Subsidiary Of Toyota Tsusho For $30.00 Per Share In Cash

Press Releases

Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)

Organon Reports Results for the Third Quarter Ended September 30, 2024

Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024

New Analysis of Organon's VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older

MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO

ROIV

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Intra-Cellular Therapies Inc. - Common Stock

Intra-Cellular Therapies

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Comments

Organon

Organon (OGN) Opciones

Organon (NYSE:OGN) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL